Determination of a drug’s safety profile is perhaps one of the most critical stages of the drug development pathway. Complications and inefficiencies with preclinical studies can create costly delays. Screening service providers help sponsors to anticipate challenges, avoid roadblocks, and expedite preclinical trials.
Tags:
Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.